Clinical Research Directory
Browse clinical research sites, groups, and studies.
Photobiomodulation Protocols in the Analgesia of Chemotherapy-induced Oral Mucositis in Children
Sponsor: University Hospital, Toulouse
Summary
Chemotherapy-induced oropharyngeal mucositis (OM) negatively impacts the quality of life of adult and pediatric patients by causing pain, dysphagia, dysgeusia and dysphonia. Photobiomodulation (PBM) by low level laser therapy (LLLT), light therapy of low level of red and infrared wavelengths (630-1000 nm) has been recommended since 2014 in patients treated with high-dose chemotherapy for bone marrow transplantation. Available pediatric studies highlighted positive/promising results of PBM with excellent safety and no adverse effects. Nevertheless, a wide variety of application parameters is described in the literature, with no consensus guidelines. Considering the lack of standardized protocol of photobiomodulation in the pediatric population as well as the burden and cost of a daily application, investigators have decided to conduct, for the first time in children of 3 years of age or older, a multicenter, randomized, double-blind, non-inferiority clinical trial to compare two PBM protocols with same PBM parameters, combining red and infrared wavelengths, but with different frequencies of laser application (daily versus every other day), in the treatment of chemotherapy-induced OM of WHO grade 2 or higher.
Official title: Double-blind, Randomized, Multi-center, Non-inferiority Clinical Trial Comparing Two Photobiomodulation Protocols in the Analgesia of Chemotherapy-induced Oral Mucositis in Children
Key Details
Gender
All
Age Range
3 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
87
Start Date
2021-05-03
Completion Date
2024-05-22
Last Updated
2026-11-05
Healthy Volunteers
No
Conditions
Interventions
LLLT applied every other day
Low-level laser therapy (LLLT) protocol combining red and infrared wavelengths applied every other day
LLLT applied daily
Low-level laser therapy (LLLT) protocol combining red and infrared wavelengths applied daily
Locations (16)
University hospital of Toulouse
Toulouse, Occitanie, France
University hospital of Angers
Angers, France
University hospital of Besançon
Besançon, France
University hospital of Grenoble
Grenoble, France
University hospital of Lille
Lille, France
University hospital of Limoges
Limoges, France
Hôpital La Timone
Marseille, France
University hospital of Nancy
Nancy, France
University Hospital of Nice
Nice, France
Armand Trousseau Hospital
Paris, France
University hospital of Poitiers
Poitiers, France
University hospital of Reims
Reims, France
University hospital of Rouen
Rouen, France
University hospital of Saint-Etienne
Saint-Etienne, France
University hospital of Strasbourg
Strasbourg, France
University Hospital of Tours
Tours, France